Elizabeth Fair, MD, PhD

Email Elizabeth
(415) 206-3514

550 16th. Street
San Francisco, CA 94158

Visit CTSI Profile
  • Associate Professor, UCSF School of Medicine

Biography

Elizabeth Fair, PhD, MPH is an infectious disease epidemiologist with a primary appointment in the Department of Medicine, Division of Pulmonary and Critical Care Medicine and affiliated faculty appointments with Global Health Sciences and the Curry International Tuberculosis Center. Dr. Fair’s research interests include tuberculosis (TB), TB/HIV, global health, and implementation/operational research. Her current work focuses on public health interventions for intensified TB case finding in high-burden settings.
With funding from NIH/NIAID K01 Mentored Research Scientist Award, Dr. Fair has worked since 2009 with the National Tuberculosis and Leprosy Program (NTLP) and National Institute of Medical Research (NIMR) in Tanzania to design and implement TB contact investigation under program conditions, and to evaluate the feasibility, yield, and cost-effectiveness of TB contact investigation in Dar es Salaam. Findings from this project led to implementation of TB contact investigation in Iringa, a rural district of Tanzania (NIH U01 ICIDR award), as well as plans for scaling-up TB contact investigation within the NTLP in Dar es Salaam (USAID funding). Using her K01 research project as a platform, she received additional funding to pilot home-based HIV testing during TB contact investigation.
She currently is working on projects exploring TB stigma in Bangladesh and is co-Investigator on an R01 grant investigating the use of mobile health for implementation of TB contact investigation in Kampala, Uganda. Dr. Fair serves as a regular consultant for the American Thoracic Society (ATS), World Health Organization (WHO), and the Dutch Tuberculosis Group (KNCV). She serves on WHO Steering Committees to develop new policies related to TB case finding and TB international standards of care (ISTC), and through the USAID funded CHALLENGE TB mechanism provides technical assistance for Indonesia, Tanzania, and Mozambique.
Dr. Fair also serves an Associate Program Director of the Master of Science (MS) in Global Health with UCSF Global Health Sciences. She co-teaches a year-long seminar series on Global Health Practice (GHS 203) and mentors and advises students.

Awards

Displaying 1 - 11 of 11

  1. Ayakaka I, Ackerman S, Ggita JM, Kajubi P, Dowdy D, Haberer JE, Fair E, Hopewell P, Handley MA, Cattamanchi A, Katamba A, Davis JL. Identifying barriers to and facilitators of tuberculosis contact investigation in Kampala, Uganda: a behavioral approach. Implement Sci. 2017 Mar 09; 12(1):33. View on Pubmed
  2. Fair E, Miller CR, Ottmani SE, Fox GJ, Hopewell PC. Tuberculosis contact investigation in low- and middle-income countries: standardized definitions and indicators. Int J Tuberc Lung Dis. 2015 Mar; 19(3):269-72. View on Pubmed
  3. Hopewell PC, Fair EL, Uplekar M. Updating the International Standards for Tuberculosis Care. Entering the era of molecular diagnostics. Ann Am Thorac Soc. 2014 Mar; 11(3):277-85. View on Pubmed
  4. World Health Organization. Recommendations for investigating contacts of persons with infectious tuberculosis in low- and middle-income countries. 2012. View on Pubmed
  5. Fair E, Hopewell PC, Pai M. International Standards for Tuberculosis Care: revisiting the cornerstones of tuberculosis care and control. Expert Rev Anti Infect Ther. 2007 Feb; 5(1):61-5.
  6. Tuberculosis Coalition for Technical Assistance. Handbook for Using the International Standards for Tuberculosis Care. 2007. View on Pubmed
  7. Aga RS, Fair E, Abernethy NF, Deriemer K, Paz EA, Kawamura LM, Small PM, Kato-Maeda M. Microevolution of the direct repeat locus of Mycobacterium tuberculosis in a strain prevalent in San Francisco. J Clin Microbiol. 2006 Apr; 44(4):1558-60. View on Pubmed
  8. Fair E, O'Meara M, Corbally N, Keogh B, Hannan M. Molecular epidemiologic investigation of tuberculosis in an area of increasing incidence in inner-city Dublin. Ir Med J. 2006 Mar; 99(3):87-90. View on Pubmed
  9. Galil K, Fair E, Mountcastle N, Britz P, Seward J. Younger age at vaccination may increase risk of varicella vaccine failure. J Infect Dis. 2002 Jul 1; 186(1):102-5. View on Pubmed
  10. Fair E, Murphy TV, Golaz A, Wharton M. Philosophic objection to vaccination as a risk for tetanus among children younger than 15 years. Pediatrics. 2002 Jan; 109(1):E2. View on Pubmed
  11. Murphy TV, Gargiullo PM, Massoudi MS, Nelson DB, Jumaan AO, Okoro CA, Zanardi LR, Setia S, Fair E, LeBaron CW, Wharton M, Livengood JR, Livingood JR. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med. 2001 Feb 22; 344(8):564-72.